This patent covers derivatives of the human chorionic gonadotrophin, as well as hCG itself, for the stimulation of hematopoiesis, reduction of cancer, and reduction of HIV.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.